SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Axsome Therapeutics Q3'26 Earnings Preview

Axsome Therapeutics is scheduled to report Q3'26 results on November 2 before the market opens. Revenue and EPS estimates are provided in the source.

AXSM

AXSM (Axsome Therapeutics, Inc.) is set to announce its Q3'26 results on November 02, before the market opens. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 249.30 million USD with EPS (earnings per share) anticipated at (0.63) USD. Learn more…